Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Nexstim closes €15.3mm dual listing in Finland and Sweden

Executive Summary

Neuromodulation company Nexstim PLC closed a €15.3mm ($19.1mm) IPO in a dual listing of 2.4mm shares at €6.35 on Nasdaq OMX First North Finland and Nasdaq OMX First North Sweden (the company listed 1.2mm shares on each exchange). Institutional investors bought the majority (95%) of the IPO shares, and retail backers the rest. The company filed for the offering last month, planning to sell 2.9mm shares for €8.70-9.80, then later increased the amount of stock (3.9mm) and decreased the price range (€6.35-6.40).
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
    • Diagnostic Imaging Equipment & Supplies
      • MRI, NMR
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies